Peripheral Nerve Stimulators Market Size Worth USD 678.01 Million by 2034 | CAGR: 10.80%
The peripheral nerve stimulators market size is expected to reach USD 678.01 Million by 2034, according to a new study by Polaris Market Research. The report “Peripheral Nerve Stimulators Market Share, Size, Trends, Industry Analysis Report: By Product Type, By End User (Hospitals and Outpatient Centers), and By Region; Market Forecast, 2026–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The peripheral nerve stimulators market provides solutions for managing chronic pain through implantable, percutaneous, and transcutaneous devices. These devices support applications in neuropathic pain, post-surgical pain, and musculoskeletal disorders to improve patient outcomes and reducing opioid dependency.
Market growth is driven by rising prevalence of chronic pain disorders, increasing healthcare expenditure, and adoption of minimally invasive neuromodulation therapies. Moreover, technological innovations in wireless and rechargeable medical devices are expanding clinical use and improving patient compliance.
Peripheral Nerve Stimulators Market Report Highlights
- North America dominated the global market with 42.0% share in 2025 through advanced healthcare infrastructure and chronic pain prevalence.
- The U.S. dominated North America capturing 78.0% share in 2025, with strong hospital networks and favorable reimbursement policies.
- Asia Pacific growing at fastest CAGR of 13.50% during 2026-2034 with the growth of increasing cases of chronic pain and improving access to healthcare.
- China held dominating position in Asia Pacific at a CAGR of 12.50% during the forecast period, due to increasing healthcare expenditure and government support for advanced medical devices.
- The implantable segment led with 45.0% share in 2025 with the highest clinical adoption and long-term performance.
- The outpatient centers segment expected to expand the fastest at a CAGR of 12.51% with the growth of minimally invasive procedures and portable devices.
- Key players in the global market include Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, B. Braun SE, Medline Industries, LP., Curonix LLC, SPR Therapeutics, Avanos Medical, Inc., Teleflex Incorporated, Curonix LLC, Xavant Technology, Vygon, and Neuspera Medical.
Request a free sample copy or read the full market insights: Peripheral Nerve Stimulators Market
Polaris Market Research has segmented the market report based on product type, end user, and region:
By Product Type (Revenue, USD Million, 2021–2034)
- Transcutaneous
- Percutaneous
- Implantable
By End User (Revenue, USD Million, 2021–2034)
- Hospitals
- Outpatient Centers
By Region (Revenue, USD Million, 2021–2034)
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherland
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Malaysia
- South Korea
- Indonesia
- Australia
- Rest of Asia Pacific
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
- Latin America
- Saudi Arabia
- UAE
- South Africa
- Israel
- Rest of South Africa